This series is not a call to avoid vaccination. It is a call to verify the foundations — before building mandates, liability exemptions, and social division upon them.
What would be needed to answer the questions from the previous five parts?
The previous parts of this series described historical patterns: methodological weaknesses, late discovery of contaminations, liability exemptions. Part 5 shows that these patterns with the mRNA vaccine are not the exception but the rule.
There is a question that is rarely asked, but that puts the entire debate in a different light:
Why do vaccine manufacturers need statutory liability protection if their product is safe?
The question “was it ever properly examined?” can also be answered historically. Three cases show what happens when the answer is “no.”
The Cutter Incident 1955 # April 1955. The USA celebrates the first polio vaccine. Mass vaccination campaign, national euphoria.
A randomized controlled trial is considered the gold standard of medicine. The logic is simple: one group gets the active substance, the other gets a placebo — and the difference shows the effect.
When discussing vaccinations, you quickly end up with the individual case: this side effect, that study, this expert. What’s rarely asked is the foundation: was the central assumption — vaccination protects — ever empirically established?
Before discussing side effects, efficacy rates, or mandates — a foundational question must be asked:
Was the central assumption that vaccination protects ever empirically established?
This isn’t a question from fringe corners of the internet. It’s a methodological question raised by physicians and researchers in peer-reviewed literature — people who have been vaccinating for decades.
This article is for all those who lost an infant — and never got an answer.
Sudden Infant Death Syndrome (SIDS) is the most common cause of death in infants between one month and one year. The cause is by definition unknown — “sudden” and “unexpected” is the medical diagnosis.
